FLUCLOXACILLIN DEMOGEN (Demogen Australia Pty Ltd trading as DEMOGEN Pharmaceuticals)
Product name
FLUCLOXACILLIN DEMOGEN
Date registered
Evaluation commenced
Decision date
Approval time
113 (255 working days)
Active ingredients
flucloxacillin sodium monohydrate
Registration type
New generic medicine
Indication
Treatment of confirmed or suspected staphylococcal infections and other Gram-positive coccal infections including pneumonia, skin and skin structure and wound infections, infected burns and cellulitis.